Nexien BioPharma's guest appearances

Nexien BioPharma

Stock Day Media

Chris Young

Grant Johnson

Brian Cox

Tommy Chong

Jonathan Herman

Jonathan Awde

Todd Davis

Timothy Sykes

Greg Hahn

Matt Goldman

Tim Jones

Peter Smith

Bob Baer

John Carter

Richard Spencer

OwlTail

Alex Wasyl

CEO Alex Wasyl of Nexien BioPharma, Inc. (OTCQB: NXEN) joins Stock Day to discuss recent acquisition, consolidation, and being engaged in the formulation, development, and commercialization of cannabinoid based drugs. OTCQB: NXEN # pharmaceutical company # cannabinoid-based pharmaceuticals # U.S. Food and Drug Administration # Colorado # drug development strategy # FDA protocols # formerly INTIVA BioPharma # healthcare # Intellectual Property # Medical Marijuana # pre-clinical and clinical pathways

<p>CEO Alex Wasyl of Nexien BioPharma, Inc. (OTCQB: NXEN) joins Stock Day to discuss recent acquisition, consolidation, and being engaged in the formulation, development, and commercialization of cannabinoid based drugs.</p> <h1>OTCQB: NXEN # pharmaceutical company # cannabinoid-based pharmaceuticals # U.S. Food and Drug Administration # Colorado # drug development strategy # FDA protocols # formerly INTIVA BioPharma # healthcare # Intellectual Property # Medical Marijuana # pre-clinical and clinical pathways</h1>

CEO Alex Wasyl of Nexien BioPharma, Inc. (OTCQB: NXEN)